Tenet Healthcare (THC) director Tammy Romo sells 7,422 shares in open-market trades

Rhea-AI Filing Summary

Tenet Healthcare Corp director Tammy Romo reported two open-market sales of Common Stock. On 2026-08-07, she sold 2,500 shares at $260.83 per share, and on 2026-08-06 she sold 4,922 shares at $264.15 per share, totaling 7,422 shares sold. Both positions were reported as direct ownership; post-transaction holdings were not stated.

Insider Trade Summary

Net Seller: 7,422 shares

Net Sell 2 txns

Insider Romo Tammy

Role Director

Sold 7,422 shs ($1.95M)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,500	$260.83	$652K
Sale	Common Stock	4,922	$264.15	$1.30M

Holdings After Transaction: Common Stock — 28,284 shares (Direct)

Key Figures

Shares sold 2026-08-06: 4,922 shares Shares sold 2026-08-07: 2,500 shares Total shares sold: 7,422 shares +2 more

5 metrics

Shares sold 2026-08-06 4,922 shares Non-derivative Common Stock sale at $264.15 per share

Shares sold 2026-08-07 2,500 shares Non-derivative Common Stock sale at $260.83 per share

Total shares sold 7,422 shares Aggregate of reported sales by director Tammy Romo

Sale price 2026-08-06 $264.15 per share Price for 4,922-share Common Stock sale

Sale price 2026-08-07 $260.83 per share Price for 2,500-share Common Stock sale

Key Terms

Common Stock, non-derivative, open market or private transaction

3 terms

Common Stock financial

"The transactions involved Tenet Healthcare’s Common Stock."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

non-derivative financial

"Each transaction is classified as a non-derivative security transaction."

open market or private transaction financial

"Transaction code S denotes a sale in open market or private transaction."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/10/2026 - 08:00 PM Accepted by SEC EDGAR 08/10/2026 - 08:00 PM Learn about SEC filing dates

FAQ

What insider activity did Tenet Healthcare (THC) report for Tammy Romo?

Tenet Healthcare director Tammy Romo reported selling a total of 7,422 shares of Common Stock in two open-market or private transactions on 2026-08-06 and 2026-08-07.

How many Tenet Healthcare (THC) shares did Tammy Romo sell on each date?

Tammy Romo sold 4,922 Tenet Healthcare shares on 2026-08-06 and 2,500 shares on 2026-08-07, for a combined sale of 7,422 shares of Common Stock.

At what prices did Tammy Romo sell Tenet Healthcare (THC) stock?

Tammy Romo’s Tenet Healthcare stock sales were reported at $264.15 per share for 4,922 shares on 2026-08-06 and $260.83 per share for 2,500 shares on 2026-08-07.

Were Tammy Romo’s Tenet Healthcare (THC) sales under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not checked, and no footnotes indicate a trading plan, so the reported Tenet Healthcare stock sales are not identified as occurring under a 10b5-1 plan.

What type of security did Tammy Romo trade in Tenet Healthcare (THC)?

The transactions reported by Tammy Romo involved Common Stock of Tenet Healthcare and are classified as non-derivative open-market or private sale transactions, rather than options or other derivative securities.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Romo Tammy

(Last) (First) (Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS TEXAS 75254

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/06/2026		S		4,922	D	$264.15	30,784	D
Common Stock	08/07/2026		S		2,500	D	$260.83	28,284	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Chad J. Wiener, as Attorney-in-fact for Tammy Romo	08/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)